Skip to main content

Peer Review reports

From: Real-world dosing of regorafenib and outcomes among patients with metastatic colorectal cancer: a retrospective analysis using US claims data

Original Submission
26 Apr 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
13 Nov 2023 Reviewed Reviewer Report
30 Mar 2024 Reviewed Reviewer Report
3 May 2024 Author responded Author comments - Tanios Bekaii-Saab
Resubmission - Version 4
3 May 2024 Submitted Manuscript version 4
13 May 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
23 May 2024 Editorially accepted
2 Aug 2024 Article published 10.1186/s12885-024-12421-4

You can find further information about peer review here.

Back to article page